Description

An allograft is tissue that is transplanted from one person to another. Soft tissue allografts are an important substitute tissue for the reconstruction of deficient ligaments, torn menisci, and osteochondral defects during knee surgery. Interest in allografts for soft tissue reconstruction has arisen from the demand to obtain a stable knee with restoration of function and protection against additional injury. The global soft tissue allografts market is set to increase by US$ 1,892.4 million from 2022 to 2028, representing a compound annual growth rate (CAGR) of 5.7% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for soft tissue allografts. The global soft tissue allografts market is segmented on the basis of product, application, end user, and region. On the basis of product, the global soft tissue allografts market has been segmented into amniotic allografts, cartilage allografts, dental allografts, meniscus allografts, tendon allografts, others. The cartilage allografts segment is estimated to account for the largest share of the global soft tissue allografts market. By application, the global soft tissue allografts market has been segmented into dentistry, orthopedic, wound care, others. The dentistry segment held the largest revenue share in 2021. Based on end user, the global soft tissue allografts market is categorized into hospitals, aesthetic centers, clinics, others. In terms of geography, the global soft tissue allografts market has been segmented into Asia Pacific, Europe, North America, Rest of the World (RoW). North America was the largest contributor to the global soft tissue allografts market in 2021.

The global soft tissue allografts market is highly competitive. The key players in the soft tissue allografts market include Allosource Inc., Arthrex Inc., Globus Medical Inc., Integra LifeSciences Corporation, Johnson & Johnson, MiMedx Group Inc., Organogenesis Inc., SeaSpine Holdings Corporation, Straumann Holding AG, Zimmer Biomet Holdings Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the soft tissue allografts market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: amniotic allografts, cartilage allografts, dental allografts, meniscus allografts, tendon allografts, others
Application: dentistry, orthopedic, wound care, others
End user: hospitals, aesthetic centers, clinics, others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global soft tissue allografts market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Soft tissue allografts market overview
Part 3. Market breakdown by product
– Amniotic allografts
– Cartilage allografts
– Dental allografts
– Meniscus allografts
– Tendon allografts
– Others
Part 4. Market breakdown by application
– Dentistry
– Orthopedic
– Wound care
– Others
Part 5. Market breakdown by end user
– Hospitals
– Aesthetic centers
– Clinics
– Others
Part 6. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 7. Key companies
– Allosource Inc.
– Arthrex Inc.
– Globus Medical, Inc.
– Integra LifeSciences Corporation
– Johnson & Johnson
– MiMedx Group Inc.
– Organogenesis, Inc.
– SeaSpine Holdings Corporation
– Straumann Holding AG
– Zimmer Biomet Holdings, Inc.
About StrategyHelix
Disclaimer